• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/80

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

80 Cards in this Set

  • Front
  • Back
common lymphild progenitor (CLP) begets? (3)
T-Cells, NK cells, B-Cells
Common myeloid progenitor (CMP) begets? (4)
Platelets, RBCs, Neutrophils, Monocytes
Different sites of Hematopoiesis in the fetus (3)
Yolk sac (0 -2 months) --> Liver and spleen (2 months - birth) --> bone marrow (5 months - birth)
Hematopoiesis in yolk sac yields what kind of cells?
Primitive erythropoiesis (EryP) --> mostly erythroid cells
Hematopoiesis in bone marrow yields what kind of cells?
definitive erythroiesus (EryD) --> myeloid and lymphoid cells
Where are hematopoietic stem cells found? (3) What are their properties (4)
Sites: Bone marriow, Peripheral blood, Cord blood. Properties: Regenreate, proliferate, Differentiate, Capable of establishing full range of hematopoiesis.
What is the usefulness of CD markers?
Useful for identifiying the cell and determining where it is in the differentiation pathway (since different CD markers appear at different stages of hematopoiesis)
CD 34. Site (2) and function
On stem cells and endothelial cells. On endothelial cells, adhesive molecule that bind L-selection. On stem cell, function is uncertain (maybe homing)
CD 117. Site and function
Stem cell epitope (it’s a tyrosine kinase domain). Receptor for the stem cell factor (SCF), also known as cKIT.
CD 113. Site and function
Ubiquitous. Also known as nectin-3. Establishes and maintains plasma membrane protrusions. Found in cadherin based adhesion junctions. Mediates cell-cell adhesion
CD 110. Site and function
Stem cells. TPO-receptor (c-mpl). Binds thrombopoietin, a cytokine that potentiates platelet health and stimulation & survival of stem cells
CDs that serve as markers for CLL and mantle cell lymphoma
CD 19, CD 5/ CD 23
Stages of erythropoeisis (6)
Proerythroblast --> Basophilic normoblast --> polychromatic normoblast --> orthochromatic normoblast --> reticulocyte --> erythrocyte
Production time for full erythropoiesis
5 Days
Changes in cell during erythropoeisis (4)
Nucleus becomes smaller. Chromatin pattern becomes more aggregated. Cytoplasm changes from blue to orange. Decrease in RNA, increase in Hb.
Stages of granulopoeisis (6)
Myeloblast --> Promyelocyte --> Myelocyte --> Metamyelocyte --> Band --> Segement
Function of EPO
Expands the erythoid progenitors by acting through the erythropoietin receptor (EPO-R). Anti-apoptotic, therefore increases progenitor survival early in erythropoiesis
Source of EPO (2)
Endogenously produced in the kidneys (peritubular capillaries. Also syhtnesided pharmacologically (used to treat anemia of end stage renal disease).
Differntial sensitivity of EPO at different stages of erythropoesis
Early erythroid precursor (burst forming unit --> BFU-E) has some EPO-R. Later erythroid precursor (cloning forming unit --> CFU-E) has many EPO-R. RBC precursors have fewer EPO-R. And finally, the mature RBC has no EPO-R
Role of JG cells in regulation of erythropoietin
JG cells sense oxygen using the Hif1 alpha factor. When O2 levels rise, Hifl alpha gets destroyed; when O2 levels drop, Hif1 alpha is retained. It complexes with Hif1 beta and this complex goes to the nucleus to singal EPO synthesis.
Role of VHL in regulation of erythropoietin
CHL protein complex is responsible for destroying Hif1 alpha. A mutation in vHL will lead to increased Hif1 alpha and hence, over signaling of EPO
G-CSF and GM-CSF (site of synthesis and function (3))
Are produced in the Bone marrow. They mobilized BM and peripheral blood pluripotent stem cells and HSCs. They increase granulocyte and moncyte counts in vivo. They improve mature neutrophil and macrophage function in vivo (GM-CSF)
Pharmacological application of G-CSF and GM-CSF
Congenital neutropenia, HIV, BM and stem cell transplantation, Stem cell harvest, Recovery post transplant, Cancer chemotherapy.
Thrombopoietin (site of synthesis and function(2))
synthesized in the liver and binds to the c-mpl receptor to: stimulate and support survival of HSCs, regulate negakaryocyte proliferation, differentiation and platelet production.
Lecture 3
RBC: Structure and function
Functions of the RBC (3)
To allow for exchange of O2 and CO2. Metabolize glucose to generate ATP. Become senescent whe metabolic activity slows
Advantage fo RBC denucleation (2)
Obviates the cardiac work of moving 1000 tons of inert nuclei (at the expense of losing 5% of hemoglobin). Transforms cell from rigid spere to supple biconcave disk
Why a biconcave disk (2)
Allows RBC to traverse capillaries that are 0.25 the diameter of erythrocte. Deformable RBC exchanges gas better than cynlindrical shape.
Cell membrane structure of RBC (3)
Lipid Bilayer, Transmembrane proteins, cytoskeleton
Band 3
A transmembrane protein that serves as the anion channel fo the cell membrane
glycophorins
These are transmembrane proteins that accoung for the red cell charge (negatively charged sialic acid) and blood group antigen. The negatively charged sialic acid prevents agglutination
Key component of cytoskeleton of RBC (3)
Ankyrin, spectrin and protein 4.1
Function of cytoskeletion of RBC
Deternines cell size and shape.
spectirn binding
Binds to actin. This binding is stabilized by protein 4.1. Ankyrin anchors the latice network (spectrin-actin complex) to the lipid bilayer. Characterisitics of this lattice network give shape to RBC and confers deformability
Rouleux formation in RBCs
These are stacks of RBCs that’s stick to each other (fibrinogen coats the sialic acid residues). This stack of RBCs have an increased mass with allows for them to move centrally in the blood vessel. Once in capillaries, Rouleux disintegrates and RBCs deform.
Hereditary Sphereocytosis
RBCs are spherical and not biconcave. Caused by deficiency in structural proteins (deficiency of ankryn or spectrin, protein 4.1 deficency, point mutation of Band 3)
Blood smear of hereditary spherocytosis
No central pallor, suggesting spherical RBCs. Some RBCs will show central pallor.
Consequence of Spherocytosis
These RBCs are not deformable and so they hemolyze in the spleen (hemolytic anemia)
Hereditary Elliptocytosis
RBCs are elliptical. Caused by spectrin dimer and tetramer abnormalities.
Consequences of Elliptocytosis
Generally, this is less of a problem than Sphereocytosis. Most patients are asymptomatic
Life span of Red cells
agerage lifespan is 120 days
Destruction of RBC (sites(2))
Spleen is the major site. Liver is an auxilliary site
How are RBCs destroyed
At 100 days, there is a slowdown of glycolysis and a decline in ATP and loss of membrane lipids. There is a stiffening of Hb-spectirn crosslinks. Naturally occuring IgG antibodies to neoantigens in response to aggregation of band 3 molecules. Removal from blood by splenic macrophages.
Lecture 4
Nutritional anemias
Causes of Hypoproliferative anemia (failure of RBC production) (3)
Insufficient stimulus to proliferate (Epo problems). Inablitiy to proliferate (B12, folate availability, cytokine therapy). Inability to synthesize adequate amounts of hemoglobin.
Sources of Iron, B12 and folic acid (3)
Liver, Red meat , fresh vegetables
Who needs the most iron in their diet?
Pre-menopausal women (about 18 micrograms)
Who needs the most vitamin B 12
Pregnant women and Breastfeeding women
Who needs the most Folic acid
Pregnant women and Breastfeeding women
Four causes of microcytic hypochrmic anemias
Fe Deficiency Anemia and Anemia of Chronic inflammation (Due to deficiency of iron). Sideroblastic Anemia (due to deficiency of protoporphyin). Thalasemia (due to mutation in globin
Sources of Fe for plasma pool of Fe-transferrin (2)
RBC destruction by the RE system. Iron absorption fro diet (1- 2 mg daily)
Iron losses from plasma pool (4)
RBC production in the bone marrow. Excreted iron (1-2 mg daily). Iron stored as Ferritin and Hemosiderin. Myoglobin and Respiratory Enzymes.
Tranferrin
An iron transfer protein that binds to receptors on cell membranes. Contains two atoms of Fe.
Ferritin
Water soluble protein-iron complex composed of an outer protein shell and iron-phosphage -dydroxide core. Can bind 4000-5000 atoms of iron
Hemosiderin
Insoluble protein-iron comlex; partially digested aggregates of ferritin
Hepcidin
Polypeptide synthesized in the liver. Acute phase reactant amd major regulator of iron homeiostatis, inhibiting iron release from cells
Characteristic history and Physical for Pt with Iron deficiency anemia
Blood Loss, Pica, Pallor, Koilonychia (indentation of fingernails
Sources of chronic blood loss
Mensturation. Pregnancy. GI bleed. GU bleed. Loss of urione hemsidering in intravascular hemolysis. Pulmonary hemosiderosis.
Diagnostic tests for Fe deficiency (4)
Bone Marrow Aspirate with Iron stain (the gold standard because a bone marrow biopsy will understimate the amount of iron present). Serum Ferritin (<10 - 20). Serum Fe/TIBC and % Saturation. Serum transferrin Receptor/
Serum Fe, TIBC (transferrin * 1.25) and Serum Ferritin in Iron deficiency
decreased Fe, increased TIBC, decreased Ferritin
Serum Fe, TIBC (transferrin * 1.25) and Serum Ferritin in ACI
Decreased Fe, decreased TIBC, increased Ferritin
Serum Fe, TIBC (tarnsferrin * 1.25) and Derum Ferritin in Sideroblastic Anemia
Increased Fe. Normal TIBC, normal to increased Serum ferritin
Treatment of iron deficiency anemia
Identify and stop abnormal blood loss, and replace iron
Iron replacement therapies (4)
Ferrous sulfate, ferrous Gluconate. Ferrous Fumarate, Iron-Polysaccharide
Things to note in anemia correction
Anemia should be half corrected in one month and fully corrected in two months with TID iron replacement
characteristics of Anemia of chronic inflammation (2)
normocytic or slightly microcytic anemia. May or may not have an identifiable chronic disease associated with it. Elevated ESR and C-reactive protein.
Mechanism of causation of ACI (3)
cytokine suppresion of erthropoiesis. Poor iron mobilization, presumanly due to increased hepcidin. Blunted erythrpoietin response.
Causes of Megaloblasatic Anemias (macrocytic anemia) (2)
Deficiency of Vitamin B 12 and Deficiency of Folic Acid.
Mechanism of causing megaloblastic anemia
Folate and B 12 are necessary for DNA replication which is essential for cell division during maturation and differentiation.
Peripheral smear of megaloblastic anemia (3)
Macroovalocytes, hypersegmented PMNs, Schistocytes.
Bone marrow in patient with megaloblastic anemia (3)
Hypercellular, Megaloblasti RBC precursors, Giant Bands and metamyelocytes
Evidence of Hemolysis in Megaloblastic anemia (3)
Increased LDH, Increased indirect bilirubin, Decreased haptoglobin
Physical exam (2)
Neurological abnormalities in B 12 are due to defects in myelin sheath production leading to: peripheral sensory nerve problems, Posterior and lateral columns
Diagnostic tests for B12 and Folate deficiency (2)
check serum levels. If normal, check Homocysteine and methyl malonic acid to detect tissue deficiencies.
B 12 deficiency ( HC and MMA)
HC is elevated, MMA is elevated
Folate deficiency (HC vs MMA)
HC is elevated, MMA is normal
Cobalmin (B 12) dependent reactions
Homocysteine --> methionine, and Methyl malonyl CoA --> Succinyl CoA
Sources of B 12 deficiency (as many as possible)
vegan, malabsorption, pernicious anemia, gastrectomy, pancreatic insufficiency, terminal ileum resection, terminal ileitis, fish tapeworm, bacterial overgrowth
Soureces of Folic Acid deficiency (as many as possible)
Decreased absorption (dietary, intestinal malabsorption, anticonvulsants), altered metabolism (ETOH and drugs), Increased utilization (pregnancy, hemolyitic anemia, malignancy)
Treatment of megaloblastic anemia
If folate deficient: folic acid (1-5 mg/ day). If B12 deficient: replace B 12 (different regiments)